37.4 US consumers cut back on Rxs due to cost

19 January 2009

USA-based Manhattan Research has issued a survey confirming earlier studies of on-line behavior by consumers, who are looking for cheaper  and more convenient alternatives to physicians' consultations and ways  of saving on health care costs. One element of the data is to compile a  list of the top-10 chronic conditions for which an estimated 37.4  million people saved money by not taking their medication.

These are: fibromyalgia; inflammatory bowel disease; generalized anxiety  disorder; chronic bronchitis; chronic pain; acute pain; adult  attention-deficit hyperactivity disorder; anxiety disorder or social  phobia; bipolar disorder; and depression.

Commenting on these findings, Jane Sarasohn-Kahn, a US health economist  specializing in Internet issues for the drug industry, said: "the issue  of patients' compliance with prescription drug regimens has challenged  drug companies, health plans and physicians for years." She added: "this  will ultimately exacerbate costs in the longer term for the individual,  the health plan, the local hospital (who might admit the patient with  complications into the emergency department) and the health system at  large."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight